
Len May
is a visionary authority in personalized medicine, revered internationally for his groundbreaking expertise in medicinal cannabis and the endocannabinoid system. As the CEO and co-founder of EndoDNA, Len is transforming the wellness landscape through patented DNA-based technology that decodes personalized genotypes, offering tailor-made health solutions. Under his forward-thinking leadership, EndoDNA has built the largest real-world efficacy database in the world, positioning the company as an unparalleled leader in precision wellness.
With over 25 years of pioneering experience and successful exits from three companies, Len is a driving force in integrating genomics and epigenetics to guide individuals toward optimized health. His work transcends theory, backed by active participation in clinical trials and contributions to peer-reviewed scientific journals, pushing the boundaries of our understanding of the endocannabinoid system and genetic expression.